The new pandemic treaty draft which will be considered at the World Health Organization’s next Intergovernmental Negotiating Body meetings in November and December is facing questions and opposition.
Advocates are encouraged that the new draft continues to include text on intellectual property waivers — despite fierce opposition from the pharmaceutical industry — and other text to achieve equity but said the language remains vague and weak on enforcement.
Mohga Kamal-Yanni, policy co-lead of the People’s Vaccine Alliance, said the current wording overall “contains too few obligations to ensure governments take these essential measures.”
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Jenny Lei Ravelo@JennyLeiRavelo
Jenny Lei Ravelo is a Devex Senior Reporter based in Manila. She covers global health, with a particular focus on the World Health Organization, and other development and humanitarian aid trends in Asia Pacific. Prior to Devex, she wrote for ABS-CBN, one of the largest broadcasting networks in the Philippines, and was a copy editor for various international scientific journals. She received her journalism degree from the University of Santo Tomas.
